ubmslatePT-logo-ubm

PT Mobile Logo

Topics:

Bipolar Disorder

Knowing One’s Genome: Are We Ready?

Once personal genetic information is readily available, what will we tell our patients?

Related content:
Inflammation: Curb Your Enthusiasm

©foxterrier2005-Shutterstock

Bipolar Disorder

Experts summarize data on the role of inflammation in psychiatric disorders, emphasizing that evidence for anti-inflammatory treatment for mood disorders is limited, and mixed.

The SRT polymorphism is one of the most well studied genetic variations affecting mood disorders. Once personal genetic information is readily available, can we help patients understand the implications of their results?

Is prevention of bipolar disorder possible? What happens before a manic or hypomanic episode that identifies this illness? Researchers asked whether there are any signs or symptoms that predict later diagnosable bipolar disorder with reasonable accuracy.

A study of adults from families with heavy genetic loading for bipolar disorder suggests that the disease has both neurodevelopmental and neurodegenerative underpinnings.

Do we really have another antipsychotic in the offing, one with a completely different mechanism than existing agents? Here: existing evidence regarding the effects of cannabidiol.

piotr_pabijan/Shutterstock

Unspecified bipolar disorder? Comorbid borderline personality disorder? Or, in the case presented here, is it time to break out the mixed specifier from DSM-5?

Anita Ponne-Shutterstock

As the intricate relationship between impaired glycemic control and bipolar disorder begins to unravel, possible directions for treatment options for the mood disorder continue to expand.

Pages

Subscribe to Bipolar Disorder on [sitename]

CME Center

Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.

By clicking Accept, you agree to become a member of the UBM Medica Community.